171 related articles for article (PubMed ID: 16871460)
1. American Diabetes Association--66th scientific sessions. Updates on drug treatments. 9-13 June 2006, Washington, DC, USA.
Jago C
IDrugs; 2006 Aug; 9(8):542-4. PubMed ID: 16871460
[No Abstract] [Full Text] [Related]
2. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
3. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
Bernard J
Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
[TBL] [Abstract][Full Text] [Related]
4. American Diabetes Association - 65th Scientific Sessions. Insulin-based therapeutics.
Erlich R
IDrugs; 2005 Aug; 8(8):613-5. PubMed ID: 16044363
[No Abstract] [Full Text] [Related]
5. American Diabetes Association--64th Scientific Sessions. Insulin. 4-8 June 2004, Orlando, FL, USA.
Mazucco RA
IDrugs; 2004 Jul; 7(7):631-2. PubMed ID: 15243860
[No Abstract] [Full Text] [Related]
6. American Diabetes Association--64th Scientific Sessions. Targeting amylin. 4-8 June 2004, Orlando, FL, USA.
Mazucco RA
IDrugs; 2004 Jul; 7(7):629-30. PubMed ID: 15243859
[No Abstract] [Full Text] [Related]
7. Drug therapy in the heart transplant recipient: Part III: common medical problems.
Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
[No Abstract] [Full Text] [Related]
8. [The treatment of diabetes in the aged with the oral antidiabetic drug Redul].
Jansen W
Med Monatsschr; 1965 Jun; 19(6):280-1. PubMed ID: 5318643
[No Abstract] [Full Text] [Related]
9. New horizons in diabetes treatment.
Marino MT
Diabetes Self Manag; 2003; 20(5):67-8, 70. PubMed ID: 14679954
[No Abstract] [Full Text] [Related]
10. Oradian, a new oral antidiabetic drug.
Bretán M; Balázsi I
Ther Hung; 1965; 13(2):59-61. PubMed ID: 5320879
[No Abstract] [Full Text] [Related]
11. Clinical trial of glycodiazine--a new oral hypoglycemic drug.
Eisenberg S; Cohen AM
Isr J Med Sci; 1966; 2(6):768-73. PubMed ID: 5334155
[No Abstract] [Full Text] [Related]
12. APD-356 (Arena).
Jandacek RJ
Curr Opin Investig Drugs; 2005 Oct; 6(10):1051-6. PubMed ID: 16259227
[TBL] [Abstract][Full Text] [Related]
13. Biotech on the rise: diabetes.
Leewe J
Biotechnol J; 2009 Feb; 4(2):172-3. PubMed ID: 19226551
[No Abstract] [Full Text] [Related]
14. Pilot evaluation of BL-H381 in treatment of diabetes mellitus.
Cohen A; Beber C; Leb S; DeFelice EA
Curr Ther Res Clin Exp; 1966 Oct; 8(10):472-8. PubMed ID: 4961023
[No Abstract] [Full Text] [Related]
15. American Diabetes Association--64th Scientific Sessions. 4-8 June 2004, Orlando, FL, USA.
Mazucco RA
IDrugs; 2004 Jul; 7(7):625-8. PubMed ID: 15243858
[No Abstract] [Full Text] [Related]
16. The use of tolazamide in the treatment of diabetes mellitus.
Beidleman B; Prevatt AL; Palmer RC
J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
[No Abstract] [Full Text] [Related]
17. Clinical experiences with the Oradian therapy of diabetes.
Csapó G; Szücs Z
Ther Hung; 1965; 13(3):119-21. PubMed ID: 5322239
[No Abstract] [Full Text] [Related]
18. Vanadium (vanadyl sulfate). Monograph.
Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
[No Abstract] [Full Text] [Related]
19. American Diabetes Association--68th Scientific Sessions. Preclinical and early clinical data with promising agents.
Glah D
IDrugs; 2008 Aug; 11(8):553-5. PubMed ID: 18683086
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of insulin sensitizers in diabetes.
Jawa A; Fonseca V
Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
